Forum Discussion
Trodelvy approved for PBS
BCNA welcomes yesterday's announcement to list Trodelvy® (sacituzumab govitecan) to the Pharmaceutical Benefits Scheme (PBS). Check out the article for full details of this news and eligibility https...
Here is the channel 9 news article if you missed it https://www.9news.com.au/national/federal-budget-2022-breast-cancer-drug-trodelvy-listed-pharmaceutical-benefits-scheme/d4f261e6-ad46-4337-a79f-0c62e5ae9123